Pfizer Ibrance India Case: ‘Willful Contempt’ Lands Local Firm In Soup
Executive Summary
An Indian court has directed a local firm to pay a specified sum to Pfizer for contempt of court in a case pertaining to its patent on palbociclib, failing which its senior executive could face a two-week prison term.